EUS-guided pancreaticobiliary procedures with the RIVOS access device

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, observational study at a single center evaluating the use of the RIVOS EUS access device for standard interventional EUS procedures. The device is designed to facilitate access, tract creation, and guidewire passage during EUS-guided interventions for pancreaticobiliary disorders. Procedures may include biliary drainage, pancreatogastrostomy, and drainage of pancreatic or peripancreatic collections. Outcomes focus on technical success and treatment outcomes using this device. The study collects data on patients who undergo EUS-guided interventions with the device as part of routine care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years
* All patients undergoing EUS-guided interventions using the RIVOS™ EUS access device

Exclusion Criteria:

* Age \< 18 years
* Patients who did not undergo EUS-guided interventions using the RIVOS™ EUS access device

Where it's running

• Orlando Health Digestive Health Institute
  Orlando, Florida, United States Recruiting

Study contacts

• Study coordinator: Ji Young Bang, MD MPH
• Email: jiyoung.bang@orlandohealth.com
• Phone: 321-842-2273

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry analyzing outcomes of therapeutic endoscopic ultrasound procedures

  This study looks at how well therapeutic endoscopic ultrasound works for people with gastrointestinal issues and what factors might affect the results.

  Recruiting IRCCS San Raffaele · Milan · NCT04813055

• CBT-248 safety in healthy adults for chronic pancreatitis support

  This early study tests CBT-248 in healthy adults to see if it is safe, how it behaves in the body, and whether meals affect its levels.

  Recruiting Phase 1 Cibus Therapeutics, Inc. · Melbourne, Victoria · NCT07905053

• Intra-arterial Y-90 Radioembolization for unresectable pancreatic cancer

  This study tests whether delivering Yttrium-90 microspheres directly into the arteries feeding unresectable pancreatic tumors is safe and tolerable while looking for early signs of effect.

  Recruiting Phase 1 National Medical Research Radiological Centre of the Ministry of Health of Russia · Obninsk · NCT07898683

• Blood protein biomarkers to help diagnose pancreatic cancer in adults

  This study tests whether blood protein biomarkers can help detect pancreatic ductal adenocarcinoma and tell it apart from chronic pancreatitis and mucinous pancreatic lesions, and whether combining markers with CA 19-9 improves accuracy.

  Recruiting Grigore T. Popa University of Medicine and Pharmacy · Iași · NCT07875582

• Microwave Ablation Feasibility for pancreatic and liver cancers guided by endoscopic ultrasound

  This study tests whether an ultrasound-guided microwave ablation device can be safely and effectively used in adults with locally advanced, unresectable, or metastatic pancreatic or liver cancers.

  Recruiting Banner Health · Gilbert, Arizona and 5 other locations · NCT07817147

• Relieving a blocked pancreatic duct in chronic pancreatitis

  This pilot study tests whether clearing a blocked pancreatic duct with endoscopy can help people with chronic pancreatitis who have mild symptoms.

  Recruiting Phase 1 Mayo Clinic · Rochester, Minnesota · NCT07810309

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.